(HealthDay)—There has been a significant decline in the risk of secondary cancers after Kaposi sarcoma (KS) in the era of highly-active antiretroviral therapy (HAART), according to a study published online Aug. 24 in JAMA ...
Aug 25, 2017
0
1
Patients with a common type of fast-growing cancer are being given fresh hope in a new clinical trial.
Aug 11, 2017
0
4
Almost half of patients with mature B cell neoplasia are faced with the ineffectiveness of existing treatments. However, they may soon benefit from new therapeutic tools relying on miRNA—a small non-coding RNA molecule ...
Aug 9, 2017
0
0
Researchers from the University of Southampton have identified why some people may become resistant to monoclonal antibodies, a common type of immunotherapy used in lymphoma treatment.
Jul 14, 2017
0
1
Follicular lymphoma is an incurable cancer that affects over 200,000 people worldwide every year. A form of non-Hodgkin lymphoma, follicular lymphoma develops when the body starts making abnormal B-cells, which are white ...
Jun 28, 2017
0
31
Today some patients suffering with mantle cell lymphoma, a type of blood cancer, can be treated with a pill called Ibrutinib, forgoing conventional chemotherapy. However, many are developing a resistance to this treatment. ...
Jun 14, 2017
0
18
Hodgkin lymphoma survivors have more severe coronary artery disease 20 years after chest irradiation, according to research presented today at ICNC 2017.
May 8, 2017
0
0
A University of Queensland researcher has found patients with non-hodgkins lymphoma are most likely to survive if they have a rich variety of T-cells.
Apr 3, 2017
0
51
Patients who are cured of Hodgkin lymphoma are at a high risk of developing a second type of cancer, particularly if they have a family history of the disease, a major new study reports.
Mar 13, 2017
0
0
Scientists in The Netherlands have revealed how gluten plays a role in the development of a rare form of cancer, for some people with coeliac disease.
Feb 28, 2017
0
76
